Bariatric and Cardiovascular Efficacy of Long-Limb Roux-en-Y Gastric Bypass: Overcoming the Limitations Inherent in Individuals

Background: The failure of the conservative treatment of obesity and its close association with cardiovascular events have lead to a consensus deeming the surgical approach to obesity as a must. The aim of this study is to determine the efficacy and safety of Roux-en-Y Gastric Bypass (RYGB) in obesity and cardiovascular risk (CVR). Methods: A comparative observational retrospective cohort study based on clinical records of patients having undergone RYGB between January 1st, 2011 and January 1st, 2014. Data related to obesity are analyzed at four stages: the consultation during which the patient opts for surgical intervention, immediately before surgery, and at 3 and 9 months following surgery. Furthermore, the risk of cardiovascular event is estimated before RYGB and during the final ninth-month assessment. Results: Rates for immediate complications and quietus complied with safety criteria, being lower in proportion than those reported in recent publications. Effects on body mass index and excess body weight were significant with a reduction in both parameters, regardless of age and gender. CVR displayed an identical tendency whereby all subjects were classified as low risk during the final assessment. Conclusion: RYGB has proven to be a safe and efficacious alternative therapy overcoming limitations inherent in individuals.